Select Page

Cyclosporin and low sorbing tubing

Home Forums Infexion Connexion Cyclosporin and low sorbing tubing

 | Click to Receive Email Notifications of Posts
  • This topic is empty.
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #70318
    Claire Rickard
    Participant

    Author:
    Claire Rickard

    Position:

    Organisation:

    State:

    HI Big Brains

    I know this is a bit off topic, but can anyone please help me on this? It
    is driving us nuts here.

    1. Where can one see the DATA on WHY we use low sorbing infusion tubing for
    cyclosporin infusion? (I know the theory, just would like to see the proof
    :o)) How does absorption vary with dose, rate, time etc?

    2. We want to extend use of this tubing for a week instead of 4 days (This
    would bring it in line with the other infusions).

    A colleague believes that the low sorbing tubing would no longer work after
    X number of days (in this case 4), and therefore if we extend it, the
    tubing may no longer present absorption.

    Yes we have asked the Drug Information Dept and they could not provide any
    data on this.

    Thinking of running some tests ourselves with a friendly biochemist if we
    can’t get a better answer!

    Best regards, Claire

    *Professor Claire Rickard RN PhD*
    c.rickard@griffith.edu.au | +61 7 3735 6460 | Skype: clairexm1 | Twitter:
    IVAD_Research |
    http://www.griffith.edu.au/health/centre-health-practice-innovation/research/acute-critical-care/intravascular-devices

    Intravascular Access Device Research Group | NHMRC Centre of Research
    Excellence in Nursing Interventions | Griffith Health Institute | Visiting
    Prince Charles Hospital

    Research frequently takes me off campus. Please contact Jenny Chan 3735
    5406 *j.chan@griffith.edu.au* or
    Jo.Wright@griffith.edu.au 3735 4886 with any urgent enquiries.

    *It’s nice to be important, but it’s more important to be nice. John Cassis.
    *

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70321
    Roel Castillo
    Participant

    Author:
    Roel Castillo

    Position:

    Organisation:

    State:

    Hi Prof

    Apologies, I don’t have a big brain. I believe it is more on the IFU (instructions for use). The device limitations/functionality are not stipulated but clearly exceeding recommended usage would be a legal liability when things go wrong. As we all know, tests were done ( in vitro) in company labs, as a requisite to TGA or FDA approval, the irony that continues to be a challenge to the clinical setting (as they are never tested in real working environment). With all due respect, it is sensible to follow device manufacturer’s IFU, the information being available to end user, covers their part of liability. The important aspect of it is obviously patient safety, for a few dollars more.

    Always happy to know the results of your tests if it proves the manufacturer’s claim or otherwise.

    Cheers
    Roel

    Roel Castillo
    Project Officer SSD
    [The Chris O`Brien Lifehouse at RPA]
    Level 5, 119-143 Missenden Road
    Camperdown NSW 2050
    PO BOX M5 Missenden Road NSW 2050

    [Lifehouse Shop]
    [Facebook: The-Chris-OBrien-Lifehouse-at-RPA][LinkedIn: The Chris O`Brien Lifehouse at RPA][Twitter: LifehouseRPA][YouTube: LifehouseatRPA]
    This email and any files transmitted with it are confidential and are intended solely for the use of the addressee. If you are not the intended recipient, then you are requested to notify us by return email and destroy any copies made. Copying, forwarding or disseminating any of this email and any file attachments without the permission of the author is strictly prohibited. Any views expressed in this message are those of the individual sender and may not necessarily reflect the views of Chris O’Brien Lifehouse at RPA or its affiliated companies.
    *hWK4nY*

    HI Big Brains

    I know this is a bit off topic, but can anyone please help me on this? It is driving us nuts here.

    1. Where can one see the DATA on WHY we use low sorbing infusion tubing for cyclosporin infusion? (I know the theory, just would like to see the proof :o)) How does absorption vary with dose, rate, time etc?

    2. We want to extend use of this tubing for a week instead of 4 days (This would bring it in line with the other infusions).

    A colleague believes that the low sorbing tubing would no longer work after X number of days (in this case 4), and therefore if we extend it, the tubing may no longer present absorption.

    Yes we have asked the Drug Information Dept and they could not provide any data on this.

    Thinking of running some tests ourselves with a friendly biochemist if we can’t get a better answer!

    Best regards, Claire

    Professor Claire Rickard RN PhD
    c.rickard@griffith.edu.au | +61 7 3735 6460 | Skype: clairexm1 | Twitter: IVAD_Research |
    http://www.griffith.edu.au/health/centre-health-practice-innovation/research/acute-critical-care/intravascular-devices

    Intravascular Access Device Research Group | NHMRC Centre of Research Excellence in Nursing Interventions | Griffith Health Institute | Visiting Scholar: Royal Brisbane & Women’s Hospital | Princess Alexandra Hospital | The Prince Charles Hospital

    Research frequently takes me off campus. Please contact Jenny Chan 3735 5406 j.chan@griffith.edu.au or Jo.Wright@griffith.edu.au 3735 4886 with any urgent enquiries.

    It’s nice to be important, but it’s more important to be nice. John Cassis.
    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au
    ______________________________________________________________________
    This email has been scanned by the Symantec Email Security.cloud service.
    For more information please visit http://www.symanteccloud.com
    ______________________________________________________________________

    ______________________________________________________________________
    This email has been scanned by the Symantec Email Security.cloud service.
    For more information please visit http://www.symanteccloud.com
    ______________________________________________________________________

    Messages posted to this list are solely the opinion of the authors, and do not represent the opinion of ACIPC.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.